Alberto M Pedroncelli

Author

Also Known As

A M Pedroncelli, A Pedroncelli, A. M. Pedroncelli, A. Pedroncelli, Alberto M Pedroncelli, Alberto M. Pedroncelli, Alberto Pedroncelli

101

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II Oregon Health & Science University Novartis (Switzerland)Neurological Surgery Massachusetts General Hospital

About

Alberto M Pedroncelli is an author at University of Naples Federico II specializing in medicine, endocrinology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	816
2	Endocrinology	5	5	421
3	Diabetes	2	2	84
4	Health Sciences	1	1	73
5	Public Health	1	1	75

Alberto M Pedroncelli

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue, The Lancet Diabetes & Endocrinology MedicineNeurologyPasireotide Versus	2014	395
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase Rosario Pivonello, Maria Fleseriu, John Newell‐Price, The Lancet Diabetes & Endocrinology Linc 3Withdrawal PhaseMedicineClinical TrialsPharmacotherapy	2020	198
Four-Year Treatment with Octreotide-Long-Acting Repeatable in 110 Acromegalic Patients: Predictive Value of Short-Term Results? Renato Cozzi, Roberto Attanasio, M Montini, The Journal of Clinical Endocrinology & Metabolism	2003	187
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease Mônica R. Gadelha, Marie Bex, Richard A. Feelders, The Journal of Clinical Endocrinology & Metabolism	2022	96
Gender- and age-related differences in the endocrine parameters of acromegaly Annamaria Colao, Giovanni Amato, Alberto M Pedroncelli, Journal of Endocrinological Investigation Endocrine MechanismNeuroendocrinologyGynecologyEndocrine ParametersFemale Reproductive Function	2002	75
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly Herbert Schmid, Thierry Brue, Annamaria Colao, Endocrine Growth Hormone-related BiomarkersMetabolic SyndromeGrowth HormoneHuman GrowthMedicine	2016	73
Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study Annamaria Colao, Marcello D. Bronstein, Thierry Brue, European Journal of Endocrinology	2020	63
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension Maria Fleseriu, John Newell‐Price, Rosario Pivonello, European Journal of Endocrinology Linc 3Week 48PharmacotherapyGlucocorticoidOptional Extension	2022	60
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study Susan L. Samson, Feng Gu, Ulla Feldt‐Rasmussen, Pituitary	2021	53
Risk factors and management of pasireotide-associated hyperglycemia in acromegaly Mônica R. Gadelha, Feng Gu, Marcello D. Bronstein, Endocrine Connections	2020	47

Page 1